BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32914363)

  • 21. Pathological changes in mice with long term cuprizone administration.
    Nomura T; Bando Y; Nakazawa H; Kanemoto S; Yoshida S
    Neurochem Int; 2019 Jun; 126():229-238. PubMed ID: 30940543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2.
    Abd El Aziz AE; Sayed RH; Sallam NA; El Sayed NS
    Inflammation; 2021 Aug; 44(4):1629-1642. PubMed ID: 33709265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
    Guglielmetti C; Le Blon D; Santermans E; Salas-Perdomo A; Daans J; De Vocht N; Shah D; Hoornaert C; Praet J; Peerlings J; Kara F; Bigot C; Mai Z; Goossens H; Hens N; Hendrix S; Verhoye M; Planas AM; Berneman Z; van der Linden A; Ponsaerts P
    Glia; 2016 Dec; 64(12):2181-2200. PubMed ID: 27685637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model.
    L M L; L P B; S G G; L O S; O M D; R V B; L M S; M Ya S
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1644-1657. PubMed ID: 33876388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
    Nunes AK; Rapôso C; Luna RL; Cruz-Höfling MA; Peixoto CA
    Cytokine; 2012 Nov; 60(2):540-51. PubMed ID: 22749439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
    Faizi M; Salimi A; Seydi E; Naserzadeh P; Kouhnavard M; Rahimi A; Pourahmad J
    Toxicol Mech Methods; 2016 May; 26(4):276-83. PubMed ID: 27088566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model.
    Han SR; Kang YH; Jeon H; Lee S; Park SJ; Song DY; Min SS; Yoo SM; Lee MS; Lee SH
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
    Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
    Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
    Petković F; Campbell IL; Gonzalez B; Castellano B
    Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.
    Shelestak J; Singhal N; Frankle L; Tomor R; Sternbach S; McDonough J; Freeman E; Clements R
    PLoS One; 2020; 15(6):e0234001. PubMed ID: 32511268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
    Krauthausen M; Saxe S; Zimmermann J; Emrich M; Heneka MT; Müller M
    J Neuroinflammation; 2014 Jun; 11():109. PubMed ID: 24930935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
    Fjær S; Bø L; Lundervold A; Myhr KM; Pavlin T; Torkildsen O; Wergeland S
    PLoS One; 2013; 8(12):e84162. PubMed ID: 24386344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating miR-146a Expression by Hydrogen Sulfide Ameliorates Motor Dysfunction and Axonal Demyelination in Cuprizone-Induced Multiple Sclerosis.
    Ghaiad HR; A Abd-Elmawla M; Gad ES; A Ahmed K; Abdelmonem M
    ACS Chem Neurosci; 2023 Sep; 14(17):3047-3058. PubMed ID: 37585620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Untargeted Metabolomic Profiling of Cuprizone-Induced Demyelination in Mouse Corpus Callosum by UPLC-Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders.
    Zhao Z; Li T; Dong X; Wang X; Zhang Z; Zhao C; Kang X; Zheng R; Li X
    Oxid Med Cell Longev; 2021; 2021():7093844. PubMed ID: 34567412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new model of cuprizone-mediated demyelination/remyelination.
    Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
    ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice.
    Yamamoto S; Gotoh M; Kawamura Y; Yamashina K; Yagishita S; Awaji T; Tanaka M; Maruyama K; Murakami-Murofushi K; Yoshikawa K
    Eur J Pharmacol; 2014 Oct; 741():17-24. PubMed ID: 25084219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
    Bihler K; Kress E; Esser S; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Brandenburg LO
    J Mol Neurosci; 2017 Jun; 62(2):232-243. PubMed ID: 28466255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
    Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
    Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactobacillus casei CRL 431 administration decreases inflammatory cytokines in a diet-induced obese mouse model.
    Novotny Núñez I; Maldonado Galdeano C; de Moreno de LeBlanc A; Perdigón G
    Nutrition; 2015; 31(7-8):1000-7. PubMed ID: 26059375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.